About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4360203
Allelic
Composition
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
Genetic
Background
MRL.Cg-Fcer1gtm1Tks Faslpr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (83 available)
Fcer1gtm1Tks mutation (1 available); any Fcer1g mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all mice diet of renal failure by 65 weeks of age with a 50% survival rate at a median age of 32-34 weeks similar to MRL-Faslpr mice

immune system
N
• MRL-Fas mice homozygous for the Fcer1gtm1Tks allele still develop glomerulonephritis in a similar manner as MRL-Faslpr mice carrying the wild-type Fcer1gtm1Tks allele
• necrotizing vasculitis with mononuclear cell infiltration, vessel wall destruction, and occasional thrombosis are observed in the interlobular arteries of the kidney
• necrotizing vasculitis of the pulmonary arteries, with mononuclear cell infiltration and vessel wall destruction occur
• spleen weight is 7- to 8-fold greater than C57BL/6 controls but is similar to MRL-Faslpr mice
• a double-negative, B220+ T cell population accumulates in the spleen and lymph nodes similar to MRL-Faslpr mice
• IgG levels are elevated compared to C57BL/6 controls but are similar to MRL-Faslpr mice
• extravasation does not occur in mice as occurs in controls when iv injected with OVA and intradermally injected with rabbit anti-OVA IgG
• anti-DNA Iglevels are elevated compared to C57BL/6 controls but are similar to MRL-Faslpr mice
• mice develop diffuse proliferative GN with mononuclear cell infiltration, mesangial and endothelial cell proliferation, and crescent formation after 16 weeks of age similar to MRL-Faslpr mice
• proteinuria, followed by renal failure, develops in all mice

renal/urinary system
• endothelial cell proliferation is noted after 16 weeks of age
• mesangial cell proliferation is noted after 16 weeks of age
• mesangial and endothelial cell proliferation after 16 weeks of age
• urinary protein concentrations increase with age similar to MRL-Faslpr mice
• mice develop diffuse proliferative GN with mononuclear cell infiltration, mesangial and endothelial cell proliferation, and crescent formation after 16 weeks of age similar to MRL-Faslpr mice
• proteinuria, followed by renal failure, develops in all mice
• crescent formation is noted after 16 weeks of age
• mice die of renal failure by 65 weeks of age similar to MRL-Faslpr mice

homeostasis/metabolism
• urinary protein concentrations increase with age similar to MRL-Faslpr mice

cardiovascular system
• endothelial cell proliferation is noted after 16 weeks of age
• various forms of medium and small vessel vasculitis occur similar to MRL-Faslpr mice
• necrotizing vasculitis with mononuclear cell infiltration, vessel wall destruction, and occasional thrombosis are observed in the interlobular arteries of the kidney
• necrotizing vasculitis of the pulmonary arteries, with mononuclear cell infiltration and vessel wall destruction occur

hematopoietic system
• spleen weight is 7- to 8-fold greater than C57BL/6 controls but is similar to MRL-Faslpr mice
• a double-negative, B220+ T cell population accumulates in the spleen and lymph nodes similar to MRL-Faslpr mice
• IgG levels are elevated compared to C57BL/6 controls but are similar to MRL-Faslpr mice

cellular
• mesangial cell proliferation is noted after 16 weeks of age
• mesangial and endothelial cell proliferation after 16 weeks of age

growth/size/body
• spleen weight is 7- to 8-fold greater than C57BL/6 controls but is similar to MRL-Faslpr mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory